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Abstract Exogenously expressed unphosphorylated sub-do-
mains of the R domain block CFTR Cl3 channels in the planar
lipid bilayer, though the block differs from block with full length
R domain. Full length R domain peptide (aa 588^855) blocks
CFTR Cl3 channels quickly, completely and permanently [1].
Two sub-domains, RD1RD2 (aa 588^805) and RD2TM (aa 672^
855), also inhibit CFTR Cl3 channels, but the block takes longer
to effect and is not complete. Shorter sequences, RD1 (aa 588^
746) and RD2 (aa 672^805), fail to effect any block. These data
suggest that either the amino-terminal or carboxy-terminal
portions of the R domain protein or its stabilized secondary
structure are critical to functional regulation.
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1. Introduction
CFTR is unique in the ABC transporter family in that
along with two membrane spanning domains and two nucleo-
tide binding domains, CFTR has a large intracellular domain
(R domain) that is involved in regulating its chloride channel
activity [1^3]. ATP binding and hydrolysis at one or both of
the nucleotide binding folds must occur [4^6] and sites within
the R domain must be phosphorylated to activate the channel
[2,7]. The R domain has an inhibitory role, since deletion of
the R domain (amino acids 708^835) relieves the requirement
for phosphorylation in order to open channels [8]. This inhib-
ition may be the result of the R domain changing charge [8] or
con¢rmation [9,10] or both. CFTR proteins mutated to re-
move all or part of the R domain have channel activity, there-
fore the R domain has not been implicated in pore formation
or ion conduction [11^13]. Exogenous R domain can block
CFTR channels in vivo [14] and in vitro [1]. 9HTEo3 cells
that have been transfected with an expression vector contain-
ing the R domain (amino acids 589^855) have reduced basal
Cl3 transport and are not stimulated by cAMP agonists in
SPQ experiments, whereas, cells transfected by the corre-
sponding empty vector have brisk basal transport of Cl3
and exhibit cAMP stimulated Cl3 current [14]. The R domain
block is accomplished in a phosphorylation dependent man-
ner [1]. In planar lipid bilayer experiments, exogenous un-
phosphorylated R domain (amino acids 589^855) inhibits
the activity of single channels of CFTR but, once phospho-
rylated, the exogenous R domain no longer inhibits channel
activity [1]. However, exogenous phosphorylated R domain
has a stimulatory e¡ect on channel activity of CFTR with
much of the R domain deleted (CFTRvR 708^835) [13^15].
Thus, the R domain has complex interactions in CFTR which
are inhibitory in the unphosphorylated state but stimulatory
when phosphorylated.
We took a reconstructive approach to determine whether a
sub-domain of the R domain is responsible for its inhibitory
activity. The R domain was divided into regions based on the
multiple domain model proposed by Dulhanty and Riordan
[9]. These investigators postulated, based on homology, that
the R domain has three distinct regions. When R domain
regions from 10 species were aligned, the ¢rst and third region
of the R domain showed more than 64% homology at the
amino acid level while the second region showed only 23%
homology. They speculated that the second region had less
constraint due to its lack of function or the versatility of its
functional domain. However, the putative phosphorylation
sites, which mostly reside within this second domain, are
highly conserved between species (s 90%). In the present
study peptides prepared based on the regions described by
Dulhanty and Riordan [9], were added to already open
CFTR channels in a bilayer system to ascertain the portion
of the R domain that exhibited the blocking ability.
2. Materials and methods
2.1. De¢nition and in vitro expression of R domain sub-domains
The R domain (from glutamate 588 to valine 855) was divided into
three separate sub-domains (Fig. 1). The ¢rst, RD1, spanned amino
acids 588 through 746. The second sub-domain, RD2, spanned amino
acids 672 through 805 and shared 75 amino acids with RD1. The third
sub-domain, RTM, included leucine 806 through valine 855. DNA
templates were constructed by polymerase chain reaction (PCR) to
amplify sequences for the sub-domains. The 5P primers contained a
Kozak sequence (gccaccatgg) and added an initial methionine to the
proteins made, which reduced context dependent leaky scanning of
the mRNA by the eukaryotic ribosomes [16]. All DNA template PCR
products were cloned into pCRII or pCR2.1 using the TA cloning kit
(Invitrogen). The sub-domains were then subcloned into pcDNA3
(Invitrogen) using PCR added BamHI and PstI sites (5P and 3P, re-
spectively). pcDNA3 has the advantage over pCRII or pCR2.1 of a
polyadenylation signal and transcription termination sequence from
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the bovine growth hormone gene. These enhanced translation of the
protein products of the sub-domains. All DNA templates were se-
quenced for base integrity and the protein products, all of which
contained the epitope sequence for mAb13-1 (aa 729^736, Genzyme),
were immunoprecipitated using this antibody and phosphorylated us-
ing protein kinase A (Fig. 1). The RD1 construct was extended from
the domain de¢ned by Dulhanty and Riordan [9] on the 3P end so that
the translation product included the epitope sequence for mAb 13-1
(mouse monoclonal anti-human CFTR exon 13, Genzyme).
The BamHI-PstI orientation allowed for sense transcription of the
R domain DNA templates from a T7 promoter. The R sub-domain
proteins (RD1, RD2, RD1RD2 and RD2TM) were synthesized in
vitro using the TnT-coupled reticulocyte lysate system (Promega).
SDS-PAGE was performed on the translation products with electro-
elution of the gel onto polyvinylidene di£uoride membrane (PVDF).
The PVDF membranes were blocked with PBS-T (50 mM sodium
phosphate, pH 7.4, 150 mM NaCl, 0.05% Tween-20) and 1% bovine
serum albumin and then incubated with antibody against the R do-
main (mAb13-1). A secondary peroxidase conjugated a⁄nity puri¢ed
goat antibody to mouse IgG was added to allow visualization of the
RDP-antibody complex using the ECL system (Amersham). For every
in vitro translation, production of R sub-domain proteins was veri¢ed
by either incubating an aliquot of the translation mix with
[35S]methionine and subsequent SDS-PAGE and autoradiography to
identify the labeled band of appropriate molecular weight or by im-
munoprecipitation and phosphorylation of an aliquot of unlabeled
translation product with antibody against the R domain of CFTR
to identify the R sub-domain proteins.
2.2. Phosphorylation inhibition
Previous work has shown that the interaction of exogenous full
length RDP on open CFTR channels is phosphorylation dependent
[1]. Protein kinase A is required in order for channels to open, but
when exogenous R domain is phosphorylated, it no longer blocks Cl3
channel activity. All sub-domains used contain at least two of the
major sites know to be phosphorylated in vivo. It is conceivable
that the actions of the sub-domains would also be phosphorylation
dependent. To stop phosphorylation once the CFTR channel has
opened, a speci¢c inhibitor of PKA, protein kinase inhibitor (PKI,
Sigma) was added to the cis chamber. A ratio of PKI/PKA of 50 ng
PKI/1 unit PKA completely blocked phosphorylation of RDP in cis
chamber bu¡er (data not shown). Experiments with R domain frag-
ments were performed with ratios of 1 Wg/unit or higher to insure a
complete block of phosphorylation.
2.3. Addition of sub-domains to captured CFTR channels
Once a CFTR channel was captured in the planar lipid bilayer,
baseline data were collected for at least 2.5 min. Then 5 Wl of PKI
at a concentration of 10 Wg/Wl was added to the cis chamber and
stirred for at least 15 s to ensure mixing. Data were again collected
for at least 2.5 min before addition of sub-domain proteins. Then 20^
50 Wl of rabbit reticulocyte lysate containing sub-domain proteins (at
a concentration of 5^20 nM) were added to the cis chamber and
stirred for at least 15 s to ensure mixing. Data were then collected
for 8^20 min, depending on the lifetime of the bilayer. All experiments
ended with either breakage of the bilayer or addition of DPC to the
trans solution, to insure identity of the CFTR channel. In order to be
con¢dent that the sub-domains did not inhibit chloride current we
only considered experiments with bilayers in which a single, or at
most, two wild-type CFTR channel(s) was (were) captured, since we
found that inhibition by intact R domain was more reliably demon-
strated in these preparations than in those containing multiple chan-
nels. All experiments were conducted under conditions in which a
concentration of peptide could be achieved that was at least three-
fold higher (¢ve-fold higher for RD1 and RD2) than the concentra-
tion of R domain protein required to inhibit channel openings, and in
which CFTR channel activity could be followed for at least 8 min
following peptide addition, since we observed that block from the
smaller peptides sometimes takes longer than block from the intact
R domain protein.
For expression of CFTR in HEK 293 cells, microsomal vesicle
collection, immunoprecipitation and planar lipid bilayer techniques
see Ma et al. [1].
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Fig. 1. R domain and sub-domains. Amino acid numbering taken
from published CFTR sequence [3] with in vivo phosphorylated ser-
ines shown. Antibody binding site (m13-1) is underlined (aa 729^
736). Exon 13 boundaries (from S589 through L830) are shown for
reference.
Table 1
RD1RD2 block of CFTR channels
Control +PKI +RD1RD2 before block +RD1RD2 after block
1 56.18 þ 5.16 39.69 þ 7.15 n.a. 21.04 þ 1.31
2 40.94 þ 3.90 40.55 þ 4.63 26.33 þ 1.45 2.07 þ 1.41
6 19 min s 19 min
3 72.52 þ 4.13 70.63 þ 4.48 61.66 þ 3.40 9.89 þ 0.820
6 6 min s 6 min
4 62.78 þ 6.98 77.89 þ 2.79 67.27 þ 3.29 0.313 þ 0.089
6 12 min s 12 min
5 31.50 þ 6.18 28.20 þ 2.61 n.a. 11.77 þ 1.42
All entries are percent mean open probability (Po) þ standard error. Data from ¢ve separate experiments (labeled in column 1) were presented.
Following incorporation of CFTR channels into the bilayer, Po were measured over a period of 2.5 to 7.5 min (control). Then 50 Wg of PKI were
added to the cis solution (+PKI), followed by the addition of RD1RD2 sub-domain (+RD1RD2). The onset of RD1RD2 e¡ect varied from 6 1
min to 19 min. Thus, data were divided into before block and after block.
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3. Results
3.1. Identi¢cation and expression of sub-domains
Dulhanty and Riordan [17] suggested, based on homology,
that the R domain may be composed of several regions. The
¢rst region spans amino acids 588^672, and was completely
contained within our proteins RD1 and RD1RD2. The sec-
ond region spans amino acids 679^798 and was contained
within our proteins RD2, RD1RD2 and RD2TM. The third
region, thought to be a tether to the seventh membrane span-
ning helix, spans amino acids 806^859 and was tested using
the RD2TM protein. These are illustrated in Fig. 1.
As shown in Fig. 2, DNA templates were transcribed and
translated into proteins (panel A) which could be immunopre-
cipitated with the R domain antibody and were phosphory-
lated by PKA (panel B). Labeling of translated proteins with
[35S]methionine showed that these proteins were the only de-
tected translation products. SDS-PAGE analysis of the pro-
teins’ mobility versus standards (Fig. 2) indicated that the
proteins migrated within 10% of their predicted size. The
DNA templates were also sequenced to insure base integ-
rity.
3.2. E¡ects of R domain sub-domains on CFTR channel
Previous studies [1,15] have shown that exogenous full
length RDP interacts with CFTR in both an inhibitory and
excitatory role. To determine the e¡ect of the sub-domains on
CFTR, these proteins were added to the cis chamber of the
planar lipid bilayer in which a CFTR channel had been cap-
tured, in concentrations up to 40-fold greater than that of the
full length RDP which produced inhibition of CFTR Cl3
channels (15 pM) [1]. Concentrations were determined based
on incorporation of [35S]methionine in the protein products
puri¢ed by SDS-PAGE and analyzed in a scintillation counter
(see Fig. 1) and ranged between 126 pM and 715 pM in the cis
chamber for RD1 and RD2. The e¡ects of addition of each of
the sub-domains on CFTR Cl3 channels are shown in Tables
1^4. Figs. 3^6 show representative traces (panel A) from the
diary plot shown in panel B. Although channel activity is
stochastic with episode open probabilities varying widely,
the mean open probability over time within an experiment
yields a useful measure of channel activity. The addition of
sub-domains RD1 and RD2 separately showed no e¡ect on
channel activity (n = 5, 5; respectively). In the experiments
with RD1 and RD2, mean open probability after protein
addition never fell below 50% of the pre-addition value. In
some experiments (n = 4) the mean open probability actually
increased, in one case, by more than 100%. In contrast, both
RD1RD2 and RD2TM showed an inhibitory e¡ect when
added to the cis chamber (n = 5, 3; respectively). In no experi-
ment with RD1RD2 and RD2TM did the mean open proba-
bility increase and, over all experiments, the mean open prob-
ability was signi¢cantly reduced (P9 0.002; Mann-Whitney
Rank Sum test). The inhibitory e¡ect of the added sub-do-
main proteins is not as rapid as the inhibitory e¡ect of the full
length R domain. As previously reported, block of the Cl3
channel activity of CFTR by the full length R domain oc-
curred within 1 min of protein addition [1]. Both RD1RD2
and RD2TM may take as long as 12 min to block (Tables 1
and 4). Previous experiments have shown that this blocking
e¡ect is speci¢c to the R domain proteins, since addition of
expressed proteins from Bore Mosaic virus and luciferase in
rabbit reticulocyte lysates failed to block channel activity even
after protracted incubation [1].
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Table 2
Lack of e¡ect of RD1 on CFTR channels
Control +PKI +RD1
1 23.08 þ 1.95 24.88 þ 2.10 23.77 þ 1.21
2 33.48 þ 3.76 25.45 þ 1.79 26.80 þ 1.00
3 11.12 þ 1.61 6.04 þ 0.729 9.55 þ 0.550
4 69.53 þ 3.31 51.26 þ 6.89 41.72 þ 3.83
5 17.20 þ 2.93 16.05 þ 3.00 34.71 þ 2.14
The experimental procedures are identical to those listed in Table 1.
Data from the ¢ve individual experiments show that RD1 had no
e¡ect on the CFTR channel.
Table 3
Lack of e¡ect of RD2 on CFTR channels
Control +PKI +RD2
1 40.19 þ 5.38 31.44 þ 3.05 38.74 þ 1.19
2 66.34 þ 3.74 60.51 þ 7.10 39.33 þ 1.95
3 26.74 þ 15.84 54.19 þ 8.45 54.08 þ 6.01
4 56.66 þ 1.94 39.23 þ 2.33 34.19 þ 1.65
5 46.94 þ 5.81 35.26 þ 2.76 24.59 þ 1.64
See Table 1 for legend. Five data show that RD2 had no e¡ect on the
CFTR channel. For representative single channel records, see Fig. 5.
Fig. 2. Expression of R domain sub-domain in reticulocyte lysate. Panel A: [35S]methionine labeled proteins expressed in rabbit reticulocyte ly-
sates: Lane 1, protein marker (Amersham); lane 2, RDP full length; lane 3, RD1RD2; lane 4, RD2; lane 5, RD2TM; lane 6, RD1. Panel B:
Samples from panel A that were immunoprecipitated with R domain antibody (m13-1, Genzyme) and phosphorylated with [32P]-Q-ATP by
PKA. Lane 1, protein marker; lane 2, RDP full length; lane 3, RD1RD2; lane 4, RD2; lane 5, RD2TM; lane 6, RD1.
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4. Discussion
Unphosphorylated exogenous R domain protein (aa 588^
855) inhibits CFTR channel openings when applied to the
intracellular side of the channel captured in the planar lipid
bilayer. This inhibition is observed at concentrations of R
domain as low as 15 pM and occurs within 1^2 min of addi-
tion of the exogenous R domain protein [1]. However, inhib-
itory activity is lost as the exogenous R domain protein be-
comes phosphorylated, and no inhibition is observed for
CFTRvR (708^835) channels, which have normal channel
properties but do not require PKA to open [15]. These data,
taken together, suggested that the inhibitory properties of the
R domain protein are conformation dependent or charge de-
pendent and probably result not from a ‘plug’ interacting with
the channel pore, but from interaction with the nucleotide
binding domains to prevent channel openings. In order to
discover which portions of the large exogenous R domain
protein were responsible for the inhibition, we expressed por-
tions of the R domain, based on the domain model of Dul-
hanty and Riordan [9], and tested their activity in the planar
lipid bilayer system.
Using criteria presented previously, we found that two of
the R domain peptides, spanning amino acids 588^805 and
amino acids 672^855, could inhibit the CFTR channel. These
two peptides have in common amino acids 672^805, desig-
nated RD2 in the Dulhanty and Riordan model, which con-
tains three of the ¢ve phosphorylation sites used in vivo.
Apart from these sites, RD2 is not highly conserved among
species [9]. However, this RD2 domain, expressed separately,
failed to block even when applied at high concentrations for
extended periods of time. At least two explanations are pos-
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Table 4
RD2TM block of CFTR channels
Control +PKI +RD2TM before block +RD2TM after block
1 24.76 þ 3.49 23.09 þ 2.96 44.05 þ 2.78 11.26 þ 0.835
6 11 min s 11 min
2 41.76 þ 8.45 85.58 þ 4.37 50.15 þ 3.90 0.102 þ 0.038
6 2 min s 2 min
3 15.85 þ 4.73 16.95 þ 3.72 n.a. 8.71 þ 2.58
s 0 min
Data from three separate experiments are listed. See Table 1 for legend. See also Fig. 6 for representative single channel records and diary plot.
Fig. 3. Exogenous RD1RD2 blocks CFTR channel. Panel A: Rep-
resentative traces of CFTR channels in the planar lipid bilayer.
Conditions indicated above traces, as described in Section 2. Panel
B: Diary plot with conditions indicated above (control, +PKI, etc.).
Each bar is the mean of 16 episodes, two of which are displayed in
panel A. Traces from panel A are taken from the diary plot at
times indicated by symbols above plot (*, 2, V).
Fig. 4. RD1 has no e¡ect on CFTR channel. Panel A: Consecutive
traces of Cl3 currents of CFTR channels in the planar lipid mem-
branes. Conditions of each set of two traces are indicated above the
traces (control, +PKI, etc.). Each condition is described in Section
2. Panel B: Diary plot of single channel recording. Changing condi-
tions are listed above (control, +PKI, etc.). Single episode record-
ings in panel A are taken from the diary plot at times indicated (*,
2, V).
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sible for these observations. First, the active region may reside
within RD2 but require the additional extended sequence ei-
ther at the N-terminus (RD1-RD2) or C-terminus (RD2-
RTM) to stabilize the inhibitory conformation. Alternatively,
there may be two sites in the R domain capable of inhibiting
channel openings. One of these sites may reside in the RTM
region or the RD2-RTM juncture, requiring at least some
amino acids from the RTM region for full activity, and the
other must require the secondary structure conferred by the
extended sequence RD1-RD2, since neither of the overlapping
pieces of this protein, expressed separately (RD1 or RD2),
could e¡ect inhibition under these conditions. The observa-
tions of Adams and Ma [18] that a small peptide from the
RTM region can inhibit channel openings favors the second
explanation. Support for this hypothesis also comes from ex-
periments using an R domain piece containing amino acids
645 through 834 [13]. This protein, missing the last four ami-
no acids of the Adams and Ma peptide, shows no inhibition
of chloride currents in the unphosphorylated state. Since these
four amino acids are found in two peptides that block
(RD2TM and the Adams and Ma peptide), and are missing
from the non-blocking protein, they may be important in the
blocking e¡ect.
The block e¡ected by RD1RD2 and RD2TM di¡ers in
important ways from the block observed with the full length
R domain protein. The block takes longer to e¡ect, requires
higher concentrations of added protein, and appears to leave
£ickery channel openings, whereas the R domain protein
block occurred within 1^2 min and was virtually complete
[1]. These observations may be explained if the longer chain
length of the R domain protein stabilizes the inhibitory con-
formation, whereas the inhibitory conformation is less stable
in the shorter peptides. This would lower the e¡ective concen-
tration of the inhibitory form of the protein in the shorter
peptides, and also allow more rapidly reversible binding
(giving rise to the £ickery block). Alternatively, or in addition,
portions of the full length R domain protein may bind to
CFTR in a non-inhibitory fashion, improving the availability
of the inhibitory portion to its favored site of inhibition.
The £ickery block does not arise simply from the addition
of the mixture of proteins in the reticulocyte lysate prep-
aration, for it does not occur with translated luciferase protein
or Bore Mosaic virus proteins which span a spectrum of
sizes [1].
The inhibitory function of the unphosphorylated R domain
on CFTR chloride channel activity represents one important
component of the function of this region of CFTR unique
among ABC transporters. Together with the activation func-
tion of phosphorylated R domain [15], it contributes to the
precise and likely carefully graded regulation of chloride
transport by phosphorylation in vivo. The present data raise
the possibility that more than one inhibitory site may exist in
the R domain, and suggest that the activity of these site(s)
may be highly dependent on the conformation assumed by the
R domain.
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Fig. 5. RD2 has no e¡ect on CFTR channel. Panel A: Downward
de£ections in current traces indicate channel openings. Each set of
two episodes is taken from the diary plot in panel B at the times in-
dicated by the symbols (*, 2, V). Conditions indicated above traces
(control, +PKI, etc.), are described in Section 2. Panel B: Diary
plot of channel open probability with 16 episodes averaged for each
bar.
Fig. 6. Exogenous RD2TM blocks CFTR channel. Panel A: Repre-
sentative traces of CFTR channels in the planar lipid membranes.
Consecutive traces were measured at a test potential of 380 mV.
Conditions indicated above traces, as described in Section 2. Panel
B: Diary plot with conditions indicated above (control, +PKI, etc.).
Each bar is the mean of 16 episodes, two of each condition are dis-
played in panel A. Traces from panel A are taken from the diary
plot at times indicated by symbols above plot (*, 2, V).
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